Mira Pharmaceuticals Inc (MIRA)

NASDAQ
Currency in USD
1.2200
-0.0100(-0.81%)
Closed
After Hours
1.1903-0.0297(-2.4344%)
MIRA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
1.18001.2400
52 wk Range
0.51005.0100
Key Statistics
Edit
Prev. Close
1.23
Open
1.22
Day's Range
1.18-1.24
52 wk Range
0.51-5.01
Volume
235.01K
Average Volume (3m)
340.01K
1-Year Change
5.17%
Book Value / Share
0.22
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MIRA Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
17.7500
Upside
+1,354.92%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins
Show more

Mira Pharmaceuticals Inc Company Profile

MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Miami, Florida.

Compare MIRA to Peers and Sector

Metrics to compare
MIRA
Peers
Sector
Relationship
P/E Ratio
−1.8x−2.6x−0.5x
PEG Ratio
0.05−0.010.00
Price/Book
5.7x0.6x2.6x
Price / LTM Sales
-3.1x3.0x
Upside (Analyst Target)
-293.6%55.6%
Fair Value Upside
Unlock3.0%10.1%Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 17.7500
(+1,354.92% Upside)

Earnings

Latest Release
Feb 26, 2025
EPS / Forecast
-0.235 / -0.13
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

0.1580
BON
+5.97%
1.670
ENVB
-4.57%
1.570
ATAI
0.00%
0.2398
MULN
-6.25%

FAQ

What Is the Mira Pharmaceuticals (MIRA) Stock Price Today?

The Mira Pharmaceuticals stock price today is 1.22

What Stock Exchange Does Mira Pharmaceuticals Trade On?

Mira Pharmaceuticals is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Mira Pharmaceuticals?

The stock symbol for Mira Pharmaceuticals is "MIRA."

What Is the Mira Pharmaceuticals Market Cap?

As of today, Mira Pharmaceuticals market cap is 20.20M.

What is Mira Pharmaceuticals Earnings Per Share?

The Mira Pharmaceuticals EPS is -0.572.

What Is the Next Mira Pharmaceuticals Earnings Date?

Mira Pharmaceuticals will release its next earnings report on May 28, 2025.

From a Technical Analysis Perspective, Is MIRA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.